Dihexa 30mg — Vial Spec, Reconstitution Math & COA

Dihexa 30mg Overview and Laboratory Use Case

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic oligopeptide derivative derived from angiotensin IV that exhibits high affinity for hepatocyte growth factor (HGF) and its receptor, c-Met. In laboratory research, the 30mg vial format serves as a standard working unit for institutional investigators conducting medium- to high-throughput cell culture studies, Western blotting, receptor dimerization assays, and preliminary preclinical animal models.

A 30mg unit mass provides researchers with sufficient material to prepare standardized stock solutions without necessitating frequent raw powder weigh-ins, thereby minimizing exposure to atmospheric moisture and reducing gravimetric error. Investigators often select the 30mg lyophilized cake format when established protocols require consistent micromolar to millimolar working concentrations across multiple experiment runs. For laboratories seeking pre-measured solid-state formats for specialized assays, PX1 Research also maintains options such as Dihexa 10mg capsules alongside raw analytical standards across our complete research peptide catalog.

Molecular Structure, Target Binding, and Preclinical Mechanism

At the molecular level, Dihexa is characterized by its hexanoylated N-terminus and modified peptide backbone, which significantly enhances its enzymatic stability in biological matrices compared to native angiotensin IV. Preclinical in vitro assays demonstrate that Dihexa binds to localized HGF with high affinity, facilitating the dimerization of c-Met receptors and initiating downstream intracellular signaling cascades. This pathway activates intracellular signaling molecules, including focal adhesion kinase (FAK), extracellular signal-regulated kinase (ERK), and phosphoinositide 3-kinase (PI3K).

In neurobiological cell models, such as primary hippocampal or cortical neuronal cultures, exposure to nanomolar concentrations of Dihexa has been observed to induce spinogenesis and synaptogenesis. Preclinical rodent studies indicate that these structural alterations in neuronal morphology coincide with altered synaptic plasticity markers. All investigations involving Dihexa are restricted strictly to laboratory in vitro testing and non-human animal research models to elucidate c-Met-dependent signaling mechanisms.

Reconstitution Mathematics for 30mg Lyophilized Mass

Accurate volumetric reconstitution of a 30mg Dihexa vial is critical for achieving exact target concentrations in laboratory assays. Because concentration ($C$) is calculated as mass ($m$) divided by total liquid volume ($V$), adding specific solvent volumes directly yields predictable stock concentrations:

1.0 mL Diluent Addition: Yields a stock concentration of 30.0 mg/mL (30.0 µg/µL). At a molecular weight of approximately 502.65 g/mol, a 30 mg/mL solution equals a molar concentration of approximately 59.68 mM. 2.0 mL Diluent Addition: Yields a stock concentration of 15.0 mg/mL (15.0 µg/µL), equivalent to approximately 29.84 mM. 3.0 mL Diluent Addition: Yields a stock concentration of 10.0 mg/mL (10.0 µg/µL), equivalent to approximately 19.89 mM.

When preparing micro-dilutions for microplate assays (e.g., 10 nM to 1 µM working concentrations), serial dilution from a 10 mg/mL or 15 mg/mL primary stock is recommended to minimize pipetting error. Researchers utilizing complex reconstitution protocols can streamline calculations using the PX1 peptide reconstitution calculator.

Solubility Protocols and Diluent Selection

Due to the hydrophobic N-terminal hexanoyl group, Dihexa exhibits limited direct solubility in pure aqueous buffers such as standard phosphate-buffered saline (PBS) or unbuffered sterile water at high concentrations. Attempting direct reconstitution in 100% aqueous diluent at 30mg/mL often results in incomplete dissolution or persistent particulate suspension.

To achieve complete solubilization, primary reconstitution should utilize a minor fraction of organic solvent, such as laboratory-grade dimethyl sulfoxide (DMSO) or ethanol, before bringing the solution to final volume with sterile aqueous diluent. A typical laboratory protocol involves dissolving the 30mg cake in 100–200 µL of 100% DMSO, followed by gentle vortexing or brief sonication until the solution is completely clear. Once fully dissolved, the primary stock can be diluted with sterile water or bacteriostatic water to reach the desired target volume and concentration, ensuring the final organic solvent concentration remains within non-toxic thresholds for the target cell line (typically <0.1% v/v DMSO in active cell culture wells).

Aliquot Strategy and Laboratory Storage Guidelines

Lyophilized Dihexa in its original sealed vial displays optimal long-term stability when stored at -20°C to -80°C in a desiccated environment protected from light exposure. Under these conditions, the dry peptide retains structural integrity and chemical purity for extended periods as documented on the lot-specific COA.

Once reconstituted into liquid stock, freeze-thaw cycles must be strictly avoided, as repeated thermal cycling accelerates peptide degradation and precipitation. Laboratories should establish a single-use aliquot protocol immediately following reconstitution: divide the stock solution into sterile microcentrifuge tubes in volumes appropriate for single-day assay requirements (e.g., 50 µL to 100 µL aliquots). Store these working aliquots at -20°C or -80°C. Reconstituted aqueous stocks maintained at 2°C–8°C should be utilized within 24 to 48 hours to ensure analytical reproducibility.

Quality Assurance: HPLC, Mass Spectrometry, and COA Issuance

Every batch of Dihexa produced for PX1 Research undergoes strict analytical verification within an ISO 17025 accredited laboratory prior to release. Quality control protocols evaluate three core chemical criteria: purity percentage via High-Performance Liquid Chromatography (HPLC), molecular identity via Electrospray Ionization Mass Spectrometry (ESI-MS), and biological safety via bacterial endotoxin testing.

HPLC analysis verifies that the chemical purity exceeds 98.0%, confirming the absence of significant truncation sequences or synthesis byproducts. Mass spectrometry confirms the precise monoisotopic mass of the N-hexanoic-Tyr-Ile-(6) aminohexanoic amide structure. Additionally, chromogenic LAL assays ensure endotoxin levels remain below strictly defined research thresholds (<0.1 EU/mg). Researchers can verify batch metrics directly by searching their lot number in the PX1 certificate of analysis database.

Comparative Analysis of Neuro-Active Research Compounds

In preclinical neurobiology, investigators frequently evaluate Dihexa alongside other peptide and small-molecule modulators targeting neurotrophic pathways, synaptic plasticity, or central nervous system signaling cascades. Understanding the mechanistic differences between these agents assists in selecting the appropriate target for specific in vitro assays.

While Dihexa acts primarily as a high-affinity c-Met receptor agonist through the HGF signaling axis, compounds such as Semax operate principally by modulating brain-derived neurotrophic factor (BDNF) expression and melanocortin receptor activity. Similarly, Selank influences enkephalinase inhibition and GABAergic neurotransmission, whereas synthetic research modulators like Noopept target AMPA and NDMA receptor expression. Comparing these distinct pathways in controlled cellular models enables researchers to map downstream biochemical responses across varied synaptic mechanisms.

Selecting Formats: 30mg Vials vs. Alternative Fill Sizes

Selecting between a 30mg vial, smaller vial masses, or solid unit formats depends primarily on the experimental scale, duration, and equipment set of the laboratory. The 30mg vial format is particularly cost-effective and practical for high-volume applications, such as long-term animal tissue studies, binding kinetics series, or continuous microplate screening programs.

For lower-throughput exploratory work or single-assay verification, smaller lyophilized sizes prevent excess material from undergoing unnecessary storage degradation. Conversely, for standardized physical assays where precise solid mass units are required without liquid handling, pre-measured formats like Dihexa 10mg capsules offer rapid deployment options. Laboratories with custom concentration or bulk material requirements can consult our neurobiology research hub or apply for institutional access through our institutional wholesale program.

PX1 Research Supply Chain, Logistics, and Procurement

PX1 Research ensures that all research compounds are manufactured within state-of-the-art, GMP-compliant facilities located in the United States. Maintaining domestic USA production allows for strict quality control oversight and eliminates supply chain vulnerabilities associated with overseas chemical sourcing.

To maintain chain-of-custody integrity and product stability, all orders are dispatched directly from our dual distribution centers located in California and Arizona. Orders placed Monday through Friday prior to the daily cutoff time qualify for same-day shipping. Every shipment includes comprehensive documentation, temperature-controlled packaging when required, and direct linkage to batch-specific analytical COAs.